Business Description
Xenetic Biosciences is a Massachusetts-based drug development company working on new ways to fight cancer. Its primary focus is a DNase-based approach that disrupts biological structures cancer cells use to grow, spread, and resist standard treatments like chemotherapy and radiation. The company has several products in development targeting pancreatic cancer, solid tumors, and kidney disease-related anemia, and works alongside partners including Takeda Pharmaceutical and Serum Institute of India.
